Table 2 Univariate associations of clinical and pathologic features with recurrence for 871 patients with stage II colon cancer
From: Predictors of recurrence free survival for patients with stage II and III colon cancer
Patient/Tumor characteristics | Hazard ratio (95% CI) | P-value |
|---|---|---|
Year of surgery (1-year increase) | 0.97 (0.92 – 1.04) | 0.38 |
Age at surgery (10-year increase) | 0.91 (0.76 – 1.08) | 0.26 |
Sex | ||
Female | 1.0 (reference) | |
Male | 1.20 (0.79 – 1.83) | 0.40 |
Adjuvant chemotherapy† | ||
No | 1.0 (reference) | |
Yes | 1.41 (0.87 – 2.27) | 0.16 |
Tumor location | ||
Right | 1.0 (reference) | |
Sigmoid | 1.37 (0.85 – 2.19) | 0.20 |
Transverse | 0.69 (0.32 – 1.53) | 0.37 |
Left | 0.58 (0.21 – 1.61) | 0.30 |
Tumor location | ||
Right, transverse, or left | 1.0 (reference) | |
Sigmoid | 1.50 (0.95 – 2.37) | 0.08 |
Primary tumor size (20-mm increase)† | 0.96 (0.80 – 1.15) | 0.66 |
Primary tumor classification | ||
T3 | 1.0 (reference) | |
T4 | 3.17 (1.79 – 5.61) | <0.001 |
Total lymph nodes (10-node increase)† | 0.84 (0.65 – 1.07) | 0.15 |
Tumor differentiation† | ||
Well | 1.0 (reference) | |
Moderate | 1.20 (0.76 – 1.89) | 0.45 |
Poor | 1.07 (0.44 – 2.59) | 0.88 |
Tumor differentiation† | ||
Well or moderate | 1.0 (reference) | |
Poor | 0.96 (0.42 – 2.20) | 0.92 |